Vitema Pharmaceuticals

Vitema Pharmaceuticals Contract Manufacturing & Development (CDMO) Profile

Vitema Pharmaceuticals is one of Europe’s largest GMP-certified pharmaceutical manufacturing facilities with an annual capacity of 3.5 billion tablets and capsules, 4,500 tons of powders, 10 million injectables (including prefilled syringes, liquid and lyophilized injectables).

End to end capabilities: Our company offers extensive contract manufacturing services from product development to full-scale production, including specialized capabilities for oncology products and clinical trials.

Operating a 33,000 sqm state-of-the-art GMP-certified facility, Vitema is equipped for the manufacturing of therapeutic oral solids, solid oncology medicines, and oncology injectables, including lyophilization.

Boasting specialized technologies, our facility provides the infrastructure necessary to support even the most complex and challenging OSD manufacturing and packaging needs. Utilizing the latest in granulation, compression, and coating technologies, we are equipped to produce a wide range of oral solid forms, including immediate and modified release tablets, enteric coated, orally disintegrating tablets, and capsules (immediate release, modified release, pellet filled, powder filled).

Our facility includes segregated and dedicated unit for the handling of cytotoxic and oncology products.

We offer in-house advanced R&D laboratories and a bioequivalence clinical unit, authorized to conduct clinical investigations of medicinal products for human use.

Our robust quality management systems ensure that each batch meets the highest quality standards, with comprehensive testing and validation processes in place, guaranteed by the certifications we hold such as EU GMP, ISO 9001, and ISO 22000.

CDMO Services:
Finished Dosage Forms (Small Molecule Drugs); Packaging; Food Supplements Lyophilized amps/vials; Pre-Filled Syringes (PFS); Solids; Sterile Ampoules; Sterile Vials Analytical Development; Drug Delivery System; Formulation Development; ICH Stability Testing; Process Development

Year Founded:

Head Office: Sibiu,

Number of Facilities: 45323

Facility locations: Europe

Website: Visit the Vitema Pharmaceuticals website

Linkedin: Connect on Linkedin

Current Capacity: 3.5 billion tablets and capsules, 4,500 tons of powders, 10 million injectables